The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global blood culture test market was valued at US$ 4.3 Billion in 2021.
We expect the global blood culture test market to exhibit a CAGR of 8.77% during 2022-2027.
The high prevalence of several infectious diseases, along with the growing demand for blood culture tests in determining the specific pathogens causing the infection and identifying their possible treatments, is primarily driving the global blood culture test market.
The sudden outbreak of the COVID-19 pandemic has led to the increasing demand for blood culture tests to analyze specimens, detect the presence of antibodies in the blood, and identify and isolate the COVID-19-infected patients.
Based on the testing method, the global blood culture test market can be segmented into conventional and automated. Currently, conventional holds the majority of the total market share.
Based on the product, the global blood culture test market has been divided into consumables, instruments, and software and services. Among these, consumables currently exhibit a clear dominance in the market.
Based on the technology, the global blood culture test market can be categorized into culture-based technology, molecular technology, proteomic technology, and others. Currently, culture-based technology accounts for the majority of the global market share.
Based on the application, the global blood culture test market has been segregated into bacterial infections, fungal infections, and mycobacterial infections, where bacterial infections currently hold the largest market share.
Based on the end user, the global blood culture test market can be bifurcated into hospital laboratories, reference laboratories, research laboratories, and others. Currently, hospital laboratories exhibit a clear dominance in the market.
On a regional level, the market has been classified into North America, Asia Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global blood culture test market include Abbott Laboratories, Danaher Corporation, Becton, Dickinson and Company, bioMeriux SA, Bruker Corporation, Luminex Corporation, Merck KGaA, Siemens Healthcare GmbH, F.Hoffmann-La Roche Ltd., T2 Biosystems Inc., and Thermo Fisher Scientific Company.
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at